Tenet Healthcare Corporation
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $2.37B | $4.06B | $1.31B | $1.00B | $1.48B | $768.0M | $171.0M | $459.0M |
| Depreciation & Amortization | $863.0M | $818.0M | $870.0M | $841.0M | $855.0M | $857.0M | $850.0M | $802.0M |
| Depreciation | $697.0M | $646.0M | $696.0M | $669.0M | $667.0M | $685.0M | — | — |
| Amortization | $166.0M | $172.0M | $174.0M | $172.0M | $188.0M | $172.0M | $188.0M | $185.0M |
| Stock-Based Compensation | $104.0M | $67.0M | $66.0M | $56.0M | $56.0M | $44.0M | $42.0M | $46.0M |
| Net Cash from Operating Activities | $3.54B | $2.05B | $2.37B | $1.08B | $1.57B | $3.41B | $1.23B | $1.05B |
| Investing Activities | ||||||||
| Capital Expenditures | $1.01B | $931.0M | $751.0M | $762.0M | $658.0M | $540.0M | $670.0M | $617.0M |
| Business Acquisitions | $308.0M | $571.0M | $224.0M | $234.0M | $1.22B | $1.18B | $25.0M | $113.0M |
| Net Cash from Investing Activities | $-1.28B | $3.43B | $-969.0M | $-808.0M | $-714.0M | $-1.61B | $-619.0M | $-115.0M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $1.39B | $672.0M | $200.0M | $250.0M | $0 | $0 | — | — |
| Net Cash from Financing Activities | $-2.40B | $-3.69B | $-1.04B | $-1.78B | $-936.0M | $385.0M | $-763.0M | $-1.13B |
| Net Change in Cash | $-136.0M | $1.79B | $370.0M | $-1.51B | $-82.0M | $2.18B | $-149.0M | $-200.0M |
| Free Cash Flow | $2.53B | $1.12B | $1.62B | $321.0M | $910.0M | $2.87B | $563.0M | $432.0M |